Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 4,054 | 3,419 | 3,248 | 3,301 | 3,395 |
| Cost of Goods | 1,403 | 1,482 | 1,159 | 1,554 | 1,297 |
| Gross Profit | 2,651 | 1,937 | 2,089 | 1,747 | 2,098 |
| Operating Expenses | 4,990 | 6,204 | 6,382 | 5,941 | 6,912 |
| Operating Income | -1,936 | -3,785 | -4,134 | -3,640 | -4,517 |
| Other Income | 6 | 22 | -125 | 1,547 | -1,011 |
| Pre-tax Income | -1,930 | -3,763 | -4,259 | -2,093 | -5,528 |
| Net Income Continuous | -1,930 | -3,763 | -4,259 | -2,093 | -5,528 |
| Net Income | $-1,930 | $-3,763 | $-4,259 | $-2,093 | $-5,528 |
| EPS Basic Total Ops | -0.60 | -1.63 | -3.05 | -1.75 | -4.62 |
| EPS Basic Continuous Ops | -0.60 | -1.63 | -3.06 | -1.75 | -4.62 |
| EPS Diluted Total Ops | -0.60 | -1.63 | -3.05 | -1.75 | -4.62 |
| EPS Diluted Continuous Ops | -0.60 | -1.63 | -3.06 | -1.75 | -4.62 |
| EPS Diluted Before Non-Recurring Items | -0.60 | -1.63 | -3.05 | N/A | N/A |
| EBITDA(a) | $-1,791 | $-3,639 | $-3,985 | $-3,491 | $-4,369 |